Effectiveness and safety of oral anticoagulant therapy in a real-world cohort with atrial fibrillation: The SIESTA-A study protocol

INTRODUCTION: Oral anticoagulants (OACs) are first-line drugs for stroke prevention in patients with atrial fibrillation (AF). The introduction of new lines of therapy with direct oral anticoagulants (DOACs) has led to a decreased use of vitamin K antagonists (VKAs). Comparative analyses of DOACs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero-Balosa, M. C., Limón-Mora, J. A., Leal-Atienza, A., Luque-Romero, L. G., Aguado-Romeo, M. J., Isabel-Gómez, R., Molina-López, M. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686507/
https://www.ncbi.nlm.nih.gov/pubmed/38019815
http://dx.doi.org/10.1371/journal.pone.0294822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686507/
https://www.ncbi.nlm.nih.gov/pubmed/38019815
http://dx.doi.org/10.1371/journal.pone.0294822

Ejemplares similares